Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study
World Journal of Urology · 10.05.2024 · 42 (1)
DOI: 10.1007/s00345-024-04979-2 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift World Journal of Urology, online erschienen am 10.05.2024. Verfasst von Zafer Tandogdu und 18 weiteren Autor:innen. Beteiligte Einrichtung: University College London Hospitals, London, UK. drzafer@gmail.com. Hauptthemen laut MEDLINE: Urinary Tract Infections, Sepsis. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Association of Urology Research Foundation.
Abstract (Originalsprache)
Purpose
To provide a descriptive report of mortality and morbidity in the first 30 days of diagnosis of urosepsis. Secondary aim is to identify risk factors of unfavourable outcomes.
Methods
Prospective observational multicentre cohort study conducted from September 2014 to November 2018 in European hospitals. Adult patients (≥ 18 years) diagnosed with acute urosepsis according to Sepsis-2 criteria with confirmed microbiological infection were included. Outcomes were classified in one of four health states: death, multiple organ failure, single organ failure, and recovery at day 30 from onset of urosepsis. Descriptive statistics and ordinal logistic regression analysis was performed.
Results
Three hundred and fifty four patients were recruited, and 30-day mortality rate was 2.8%, rising to 4.6% for severe sepsis. All patients who died had a SOFA score of ≥ 2 at diagnosis. Upon initial diagnosis, 79% ( n = 281) of patients presented with OF. Within 30 days, an additional 5% developed OF, resulting in a total of 84% affected. Charlson score (OR 1.14 CI 1.01–1.28), patients with respiratory failure at baseline (OR 2.35, CI 1.32–4.21), ICU admission within the past 12 months (OR 2.05, CI 1.00–4.19), obstruction causative of urosepsis (OR 1.76, CI 1.02–3.05), urosepsis with multi-drug-resistant(MDR) pathogens (OR 2.01, CI 1.15–3.53), and SOFA baseline score ≥ 2 (OR 2.74, CI 1.49–5.07) are significantly associated with day 30 outcomes (OF and death).
Conclusions
Impact of comorbidities and MDR pathogens on outcomes highlights the existence of a distinct group of patients who are prone to mortality and morbidity. These findings underscore the need for the development of pragmatic classifications to better assess the severity of UTIs and guide management strategies. Study registration : Clinicaltrials.gov registration number NCT02380170.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University College London Hospitals, London, UK. drzafer@gmail.com.
- Division of Surgery and Interventional Science, University College London, Charles Bell Housr, London, UK. drzafer@gmail.com.
- South Pest Teaching Hospital, Budapest, Hungary.
- University Clinic for Surgical Diseases "St. Naum Ohridski" Skopje, Skopje, Republic of North Macedonia.
- Gaziosmanpasa Taksim Teaching Hospital, Istanbul, Turkey.
- Urology Department, Oslo University Hospital, Oslo, Norway.
Förderung
- European Association of Urology Research Foundation
Zitieren
APA
Tandogdu, Z., Koves, B., Ristovski, S., Balci, M. B. C., Rennesund, K., Gravas, S., Nale, D., Medina-Polo, J., Garabášová, M. K., Costantini, E., Cano-Valasco, J., Glavinova, M. S., Bruyere, F., Perepanova, T., Kulchavenya, E., Cek, M., Wagenlehner, F., Johansen, T. E. B., & SERPENS Investigators (2024). Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study. World Journal of Urology, 42(1). https://doi.org/10.1007/s00345-024-04979-2
Vancouver
Tandogdu Z, Koves B, Ristovski S, Balci MBC, Rennesund K, Gravas S, et al. Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study. World Journal of Urology. 2024;42(1). doi:10.1007/s00345-024-04979-2
BibTeX
@article{Tandogdu2024,
author = {Tandogdu, Zafer and Koves, Bela and Ristovski, Slobodan and Balci, Mustafa Bahadir Can and Rennesund, Kristin and Gravas, Stavros and Nale, DjordJe and Medina-Polo, José and Garabášová, Mária Kopilec and Costantini, Elisabetta and Cano-Valasco, Jorge and Glavinova, Maja Sofronievska and Bruyere, Franck and Perepanova, Tamara and Kulchavenya, Ekaterina and Cek, Mete and Wagenlehner, Florian and Johansen, Truls Erik Bjerklund and SERPENS Investigators, SERPENS Investigators},
title = {Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study},
journal = {World Journal of Urology},
year = {2024},
volume = {42},
number = {1},
doi = {10.1007/s00345-024-04979-2}
}
EUVIMED